A B S T R A C T In previous studies subjects with familial polyposis, the autosomal dominant disease leading to colon cancer, excreted higher levels of fecal cholesterol than normal subjects, with decreased conversion to degradation products. Findings suggested fecal cholesterol degradation as a marker of hereditary predisposition to colon cancer. Current measurements now have shown that affected individuals and asymptomatic progeny in a second population group with inherited predisposition to colon cancer are low converters of fecal cholesterol. The latter group consisted of highly colon cancer prone families without polyposis, in which pattems of inheritance similar to the autosomal dominant pattern of familial polyposis were observed. 24-h stool collections were obtained from 72 subjects who consumed mixed western diets. Mean percent degradation of fecal cholesterol to coprostanol, coprostanone, cholestanol, and cholestanone revealed significant decreases in fecal cholesterol conversion in affected and asymptomatic subjects in colon cancer prone families without polyposis (P < 0.001) compared to controls. This is in addition to those with familial polyposis (P < 0.001), and extends this marker of colon cancer susceptibility to a second population group with hereditary predisposition to colonic neoplasia.
INTRODUCTION
Subjects with the dominant inherited disease, familial polyposis coli, excrete higher levels of fecal cholesterol than normal subjects, and show decreased conversion of fecal cholesterol to its degradation products (1-3). We now have extended these observations to a second population group at high risk for colon cancer, i.e., strongly colon cancer prone families in which individuals do not develop polyposis, and where the pattern of cancer inheritance resembles the autosomal dominant pattern of familial polyposis (4, 5) . In this second group, affected individuals and a high fraction of asymptomatic progeny also had significantly increased levels of fecal cholesterol with low cholesterol conversion. This was in contrast to control subjects in the general population. verify the presence of polyposis in the FP, group, and to verify the absence of polyps and colon cancer in the other groups. All subjects were consuming a mixed western diet, and had not received antibiotics for 4 wk before the measurements. Individual 24-h stool samples were collected and analyzed in duplicate for cholesterol and its microbial metabolites, using thin layer chromatographic and gas liquid chromatographic methods as described (6) . Table I shows levels of fecal neutral sterols and degradation products in the three groups. In controls, the mean level of fecal cholesterol was 3.2+±0.50 mglg SE dry feces; the mean percent cholesterol degradation to coprostanol, coprostanone, cholestanol, and (4, 5) . These families have a higher incidence of colon cancer and generally earlier age of onset, than reported in other series (7) where familial associations have been noted. Individuals in the FCC group, and individuals in the general population who have first and second degree relatives with colon cancer, are found with higher frequency than are individuals with familial polyposis coli (7, 8) . Average values (+SE) of cholesterol and degradation products in each population group are shown. In the last column for each population group, the average percent degradation is shown where a given patient's percent degradation is defined as degradation products divided by total neutral sterols x 100. * Percent degradation of cholesterol in the group differs significantly from the controls (P < 0.001) with the Student's t test.
METHODS

RESULTS
I II
A tentative lower limit of 60% for degradation of cholesterol in the control group has been derived from the mean value minus two standard deviations. Low converters have been defined as having percent degradation <60% and high converters having values >60%.
Factors leading to decreased conversion of cholesterol in fecal specimens of these colon cancer prone subjects have not been elucidated. Possibilities that have been considered include the microbial degradation of cholesterol which could differ in the two groups (9, 10) and the metabolism of cholesterol in intestinal cells which might be modified in these individuals with hereditary predisposition to colon cancer.
Wilkins and Hackman (10) have shown that two patterns of neutral steroid conversion exist in subjects in the general population; a larger population group is characterized by extensive conversion of cholesterol to its degradation products, and a minor group is characterized by little or no fecal conversion of cholesterol. These patterns were generally found to be stable over long periods of time, and the possibility that differences in risk level for colon cancer might be associated with cholesterol excretion has been considered (10, 11) .
Previous studies also have indicated that fecal cholesterol conversion patterns were equally distributed between males and females, were independent of age (10) , and increased after ileoproctostomy (2); conversion rate was not directly related to fecal transit time (10 (16) .
In attempts to improve the surveillance of individuals at high risk for cancer of the large intestine, it is important to develop indices that will identify these subjects before they develop advanced disease. 
